| الإنجليزية | العربية | الرئسية | تسجيل الدخول |

البحوث العلمية

2021

COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: a population-based study

2021-01
medRxiv
This population-based study aimed to evaluate the seroprevalence of antibodies to SARS-CoV-2 in Duhok City, Kurdistan Region of Iraq
2020

The Prevalence of Hepatitis B and C Virus Infections in the Couples Attending a Premarital Screening Program in Zakho City, Kurdistan Region of Iraq

2020-04
Journal Zahedan Journal of Research in Medical Sciences (القضية : 2) (الحجم : 23)
Hepatitis B and C virus (HBV and HCV) infections are major global health issues and the leading causes of liver cirrhosis and hepatocellular carcinoma
2019

The prevalence of hepatitis B and C virus in healthy women in Zakho city, Kurdistan Region of Iraq: a brief report

2019-12
Journal of Kermanshah University of Medical Sciences (القضية : 4) (الحجم : 23)
Infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are major global public health problems. Infection with such viruses is commonly associated with liver cirrhosis and hepatocellular carcinoma

The Distributions of HCV Genotypes in Hemodialysis Patients in Iraq

2019-10
Iranian Journal of Medical Microbiology (الحجم : 13)
During the study period between May 2017 and May 2019, 255 patients were recruited. Recruiting patients were undergoing regular hemodialysis for renal failure in seven dialysis centers in Medical City Hospital, Al-Karama Teaching Hospital, Al-Kadymia Teaching Hospital-Baghdad, Al-Basra Teaching Hospital, Duhok dialysis center and Zakho dialysis center. A 5cc syringe and needle were used to obtain five ml of blood from subjects. Then, the samples were centrifuged at 1500 rpm for 3 min to obtain serum
2016

• Doppler- Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq. PloS ONE 11(9):e0162036. doi:10.1371/journal.pone.0162036.

2016-09
Plos ONE (الحجم : 9)
To determine the frequency, clinical and laboratory associations of pulmonary hypertension in Iraqi Kurds with sickle cell anemia, a total of ninety four such patients attending a major hemoglobinopathy center in Iraqi Kurdistan were enrolled. All patients were re-evaluated clinically and had their blood counts, HbF, serum ferritin, LDH, renal and liver function assessed. Transthoracic Doppler echocardiography with measurement of tricuspid valve regurgitant jet velocity (TRV) was performed. A TRV in excess of 2.8 m/s was considered for the purposes of this study as indicative of pulmonary hypertension (PH). The prevalence of TRV in excess of 2.8m/s was 10.6%. By univariate analysis: significantly higher reticulocyte count, more frequent blood transfusions and pain episodes were encountered in the PH group as compared to the non-PH group (p = 0.001, 0.045 and 0.02 respectively). Moreover, PH patients had significantly higher mean right atrial area, left atrial size, E wave/A wave ratio and ejection fraction by echocardiography (p = 0.027, 0.037, <0.001 and 0.008 respectively). Except for reticulocyte count none of the other parameters remained significant by multivariate analysis (p = 0.024). In conclusion the current study revealed that pulmonary hypertension is rather frequent among Iraqi Kurds with sickle cell anemia, and identified reticulocyte count as an independently associated parameter with PH in this population. Future prospective studies including right heart catheterization and appropriate medical intervention are warranted.
2010

• Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficient Variants among the Kurdish population of Northern Iraq. BMC Blood Disorders 2010, 10.6. biomedcentral.com/1471-2326/10/6.

2010-07
BMC Blood Disorder (الحجم : 9)
Background: Glucose-6-Phosphate dehydrogenase (G6PD) is a key enzyme of the pentose monophosphate pathway, and its deficiency is the most common inherited enzymopathy worldwide. G6PD deficiency is common among Iraqis, including those of the Kurdish ethnic group, however no study of significance has ever addressed the molecular basis of this disorder in this population. The aim of this study is to determine the prevalence of this enzymopathy and its molecular basis among Iraqi Kurds. Methods: A total of 580 healthy male Kurdish Iraqis randomly selected from a main regional premarital screening center in Northern Iraq were screened for G6PD deficiency using methemoglobin reduction test. The results were confirmed by quantitative enzyme assay for the cases that showed G6PD deficiency. DNA analysis was performed on 115 G6PD deficient subjects, 50 from the premarital screening group and 65 unrelated Kurdish male patients with documented acute hemolytic episodes due to G6PD deficiency. Analysis was performed using polymerase chain reaction/restriction fragment length polymorphism for five deficient molecular variants, namely G6PD Mediterranean (563 C→T), G6PD Chatham (1003 G→A), G6PD A- (202 G→A), G6PD Aures (143 T→C) and G6PD Cosenza (1376 G→C), as well as the silent 1311 (C→T) mutation. Results: Among 580 random Iraqi male Kurds, 63 (10.9%) had documented G6PD deficiency. Molecular studies performed on a total of 115 G6PD deficient males revealed that 101 (87.8%) had the G6PD Mediterranean variant and 10 (8.7%) had the G6PD Chatham variant. No cases of G6PD A-, G6PD Aures or G6PD Cosenza were identified, leaving 4 cases (3.5%) uncharacterized. Further molecular screening revealed that the silent mutation 1311 was present in 93/95 of the Mediterranean and 1/10 of the Chatham cases. Conclusions: The current study revealed a high prevalence of G6PD deficiency among Iraqi Kurdish population of Northern Iraq with most cases being due to the G6PD Mediterranean and Chatham variants. These results are similar to those reported from neighboring Iran and Turkey and to lesser extent other Mediterranean countries.

الرجوع